Global DNA & RNA Oligonucleotides Market Insights, Forecast to 2031

Report ID: 1668042 | Published Date: Sep 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 DNA Oligonucleotides
        1.2.3 RNA Oligonucleotides
    1.3 Market by Application
        1.3.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals and Clinics
        1.3.3 Biopharma Companies
        1.3.4 Academic & Research Organizations
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global DNA & RNA Oligonucleotides Market Perspective (2017-2028)
    2.2 DNA & RNA Oligonucleotides Growth Trends by Region
        2.2.1 DNA & RNA Oligonucleotides Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 DNA & RNA Oligonucleotides Historic Market Size by Region (2017-2022)
        2.2.3 DNA & RNA Oligonucleotides Forecasted Market Size by Region (2023-2028)
    2.3 DNA & RNA Oligonucleotides Market Dynamics
        2.3.1 DNA & RNA Oligonucleotides Industry Trends
        2.3.2 DNA & RNA Oligonucleotides Market Drivers
        2.3.3 DNA & RNA Oligonucleotides Market Challenges
        2.3.4 DNA & RNA Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top DNA & RNA Oligonucleotides Players by Revenue
        3.1.1 Global Top DNA & RNA Oligonucleotides Players by Revenue (2017-2022)
        3.1.2 Global DNA & RNA Oligonucleotides Revenue Market Share by Players (2017-2022)
    3.2 Global DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by DNA & RNA Oligonucleotides Revenue
    3.4 Global DNA & RNA Oligonucleotides Market Concentration Ratio
        3.4.1 Global DNA & RNA Oligonucleotides Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by DNA & RNA Oligonucleotides Revenue in 2021
    3.5 DNA & RNA Oligonucleotides Key Players Head office and Area Served
    3.6 Key Players DNA & RNA Oligonucleotides Product Solution and Service
    3.7 Date of Enter into DNA & RNA Oligonucleotides Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 DNA & RNA Oligonucleotides Breakdown Data by Type
    4.1 Global DNA & RNA Oligonucleotides Historic Market Size by Type (2017-2022)
    4.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2023-2028)
5 DNA & RNA Oligonucleotides Breakdown Data by Application
    5.1 Global DNA & RNA Oligonucleotides Historic Market Size by Application (2017-2022)
    5.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America DNA & RNA Oligonucleotides Market Size (2017-2028)
    6.2 North America DNA & RNA Oligonucleotides Market Size by Type
        6.2.1 North America DNA & RNA Oligonucleotides Market Size by Type (2017-2022)
        6.2.2 North America DNA & RNA Oligonucleotides Market Size by Type (2023-2028)
        6.2.3 North America DNA & RNA Oligonucleotides Market Share by Type (2017-2028)
    6.3 North America DNA & RNA Oligonucleotides Market Size by Application
        6.3.1 North America DNA & RNA Oligonucleotides Market Size by Application (2017-2022)
        6.3.2 North America DNA & RNA Oligonucleotides Market Size by Application (2023-2028)
        6.3.3 North America DNA & RNA Oligonucleotides Market Share by Application (2017-2028)
    6.4 North America DNA & RNA Oligonucleotides Market Size by Country
        6.4.1 North America DNA & RNA Oligonucleotides Market Size by Country (2017-2022)
        6.4.2 North America DNA & RNA Oligonucleotides Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe DNA & RNA Oligonucleotides Market Size (2017-2028)
    7.2 Europe DNA & RNA Oligonucleotides Market Size by Type
        7.2.1 Europe DNA & RNA Oligonucleotides Market Size by Type (2017-2022)
        7.2.2 Europe DNA & RNA Oligonucleotides Market Size by Type (2023-2028)
        7.2.3 Europe DNA & RNA Oligonucleotides Market Share by Type (2017-2028)
    7.3 Europe DNA & RNA Oligonucleotides Market Size by Application
        7.3.1 Europe DNA & RNA Oligonucleotides Market Size by Application (2017-2022)
        7.3.2 Europe DNA & RNA Oligonucleotides Market Size by Application (2023-2028)
        7.3.3 Europe DNA & RNA Oligonucleotides Market Share by Application (2017-2028)
    7.4 Europe DNA & RNA Oligonucleotides Market Size by Country
        7.4.1 Europe DNA & RNA Oligonucleotides Market Size by Country (2017-2022)
        7.4.2 Europe DNA & RNA Oligonucleotides Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size (2017-2028)
    8.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type
        8.2.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific DNA & RNA Oligonucleotides Market Share by Type (2017-2028)
    8.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application
        8.3.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific DNA & RNA Oligonucleotides Market Share by Application (2017-2028)
    8.4 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region
        8.4.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America DNA & RNA Oligonucleotides Market Size (2017-2028)
    9.2 Latin America DNA & RNA Oligonucleotides Market Size by Type
        9.2.1 Latin America DNA & RNA Oligonucleotides Market Size by Type (2017-2022)
        9.2.2 Latin America DNA & RNA Oligonucleotides Market Size by Type (2023-2028)
        9.2.3 Latin America DNA & RNA Oligonucleotides Market Share by Type (2017-2028)
    9.3 Latin America DNA & RNA Oligonucleotides Market Size by Application
        9.3.1 Latin America DNA & RNA Oligonucleotides Market Size by Application (2017-2022)
        9.3.2 Latin America DNA & RNA Oligonucleotides Market Size by Application (2023-2028)
        9.3.3 Latin America DNA & RNA Oligonucleotides Market Share by Application (2017-2028)
    9.4 Latin America DNA & RNA Oligonucleotides Market Size by Country
        9.4.1 Latin America DNA & RNA Oligonucleotides Market Size by Country (2017-2022)
        9.4.2 Latin America DNA & RNA Oligonucleotides Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size (2017-2028)
    10.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type
        10.2.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa DNA & RNA Oligonucleotides Market Share by Type (2017-2028)
    10.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application
        10.3.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa DNA & RNA Oligonucleotides Market Share by Application (2017-2028)
    10.4 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country
        10.4.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Eurofins Scientific
        11.1.1 Eurofins Scientific Company Details
        11.1.2 Eurofins Scientific Business Overview
        11.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Introduction
        11.1.4 Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.1.5 Eurofins Scientific Recent Developments
    11.2 Natera
        11.2.1 Natera Company Details
        11.2.2 Natera Business Overview
        11.2.3 Natera DNA & RNA Oligonucleotides Introduction
        11.2.4 Natera Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.2.5 Natera Recent Developments
    11.3 BGI
        11.3.1 BGI Company Details
        11.3.2 BGI Business Overview
        11.3.3 BGI DNA & RNA Oligonucleotides Introduction
        11.3.4 BGI Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.3.5 BGI Recent Developments
    11.4 Illumina
        11.4.1 Illumina Company Details
        11.4.2 Illumina Business Overview
        11.4.3 Illumina DNA & RNA Oligonucleotides Introduction
        11.4.4 Illumina Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.4.5 Illumina Recent Developments
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche DNA & RNA Oligonucleotides Introduction
        11.5.4 Roche Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.5.5 Roche Recent Developments
    11.6 LabCorp
        11.6.1 LabCorp Company Details
        11.6.2 LabCorp Business Overview
        11.6.3 LabCorp DNA & RNA Oligonucleotides Introduction
        11.6.4 LabCorp Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.6.5 LabCorp Recent Developments
    11.7 Berry Genomics
        11.7.1 Berry Genomics Company Details
        11.7.2 Berry Genomics Business Overview
        11.7.3 Berry Genomics DNA & RNA Oligonucleotides Introduction
        11.7.4 Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.7.5 Berry Genomics Recent Developments
    11.8 Brooks Life Sciences
        11.8.1 Brooks Life Sciences Company Details
        11.8.2 Brooks Life Sciences Business Overview
        11.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Introduction
        11.8.4 Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.8.5 Brooks Life Sciences Recent Developments
    11.9 Macrogen
        11.9.1 Macrogen Company Details
        11.9.2 Macrogen Business Overview
        11.9.3 Macrogen DNA & RNA Oligonucleotides Introduction
        11.9.4 Macrogen Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.9.5 Macrogen Recent Developments
    11.10 Genotypic Technology
        11.10.1 Genotypic Technology Company Details
        11.10.2 Genotypic Technology Business Overview
        11.10.3 Genotypic Technology DNA & RNA Oligonucleotides Introduction
        11.10.4 Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.10.5 Genotypic Technology Recent Developments
    11.11 Dna Link
        11.11.1 Dna Link Company Details
        11.11.2 Dna Link Business Overview
        11.11.3 Dna Link DNA & RNA Oligonucleotides Introduction
        11.11.4 Dna Link Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
        11.11.5 Dna Link Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of DNA Oligonucleotides
    Table 3. Key Players of RNA Oligonucleotides
    Table 4. Global DNA & RNA Oligonucleotides Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global DNA & RNA Oligonucleotides Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global DNA & RNA Oligonucleotides Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global DNA & RNA Oligonucleotides Market Share by Region (2017-2022)
    Table 8. Global DNA & RNA Oligonucleotides Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global DNA & RNA Oligonucleotides Market Share by Region (2023-2028)
    Table 10. DNA & RNA Oligonucleotides Market Trends
    Table 11. DNA & RNA Oligonucleotides Market Drivers
    Table 12. DNA & RNA Oligonucleotides Market Challenges
    Table 13. DNA & RNA Oligonucleotides Market Restraints
    Table 14. Global DNA & RNA Oligonucleotides Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global DNA & RNA Oligonucleotides Revenue Share by Players (2017-2022)
    Table 16. Global Top DNA & RNA Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2021)
    Table 17. Ranking of Global Top DNA & RNA Oligonucleotides Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by DNA & RNA Oligonucleotides Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players DNA & RNA Oligonucleotides Product Solution and Service
    Table 21. Date of Enter into DNA & RNA Oligonucleotides Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global DNA & RNA Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2017-2022)
    Table 25. Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2023-2028)
    Table 27. Global DNA & RNA Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global DNA & RNA Oligonucleotides Revenue Share by Application (2017-2022)
    Table 29. Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global DNA & RNA Oligonucleotides Revenue Share by Application (2023-2028)
    Table 31. North America DNA & RNA Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America DNA & RNA Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America DNA & RNA Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America DNA & RNA Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe DNA & RNA Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe DNA & RNA Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe DNA & RNA Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe DNA & RNA Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific DNA & RNA Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific DNA & RNA Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific DNA & RNA Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific DNA & RNA Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific DNA & RNA Oligonucleotides Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific DNA & RNA Oligonucleotides Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America DNA & RNA Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America DNA & RNA Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America DNA & RNA Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America DNA & RNA Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa DNA & RNA Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa DNA & RNA Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa DNA & RNA Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa DNA & RNA Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Eurofins Scientific Company Details
    Table 62. Eurofins Scientific Business Overview
    Table 63. Eurofins Scientific DNA & RNA Oligonucleotides Product
    Table 64. Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 65. Eurofins Scientific Recent Developments
    Table 66. Natera Company Details
    Table 67. Natera Business Overview
    Table 68. Natera DNA & RNA Oligonucleotides Product
    Table 69. Natera Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 70. Natera Recent Developments
    Table 71. BGI Company Details
    Table 72. BGI Business Overview
    Table 73. BGI DNA & RNA Oligonucleotides Product
    Table 74. BGI Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 75. BGI Recent Developments
    Table 76. Illumina Company Details
    Table 77. Illumina Business Overview
    Table 78. Illumina DNA & RNA Oligonucleotides Product
    Table 79. Illumina Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 80. Illumina Recent Developments
    Table 81. Roche Company Details
    Table 82. Roche Business Overview
    Table 83. Roche DNA & RNA Oligonucleotides Product
    Table 84. Roche Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 85. Roche Recent Developments
    Table 86. LabCorp Company Details
    Table 87. LabCorp Business Overview
    Table 88. LabCorp DNA & RNA Oligonucleotides Product
    Table 89. LabCorp Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 90. LabCorp Recent Developments
    Table 91. Berry Genomics Company Details
    Table 92. Berry Genomics Business Overview
    Table 93. Berry Genomics DNA & RNA Oligonucleotides Product
    Table 94. Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 95. Berry Genomics Recent Developments
    Table 96. Brooks Life Sciences Company Details
    Table 97. Brooks Life Sciences Business Overview
    Table 98. Brooks Life Sciences DNA & RNA Oligonucleotides Product
    Table 99. Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 100. Brooks Life Sciences Recent Developments
    Table 101. Macrogen Company Details
    Table 102. Macrogen Business Overview
    Table 103. Macrogen DNA & RNA Oligonucleotides Product
    Table 104. Macrogen Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 105. Macrogen Recent Developments
    Table 106. Genotypic Technology Company Details
    Table 107. Genotypic Technology Business Overview
    Table 108. Genotypic Technology DNA & RNA Oligonucleotides Product
    Table 109. Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 110. Genotypic Technology Recent Developments
    Table 111. Dna Link Company Details
    Table 112. Dna Link Business Overview
    Table 113. Dna Link DNA & RNA Oligonucleotides Product
    Table 114. Dna Link Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 115. Dna Link Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global DNA & RNA Oligonucleotides Market Share by Type: 2021 VS 2028
    Figure 2. DNA Oligonucleotides Features
    Figure 3. RNA Oligonucleotides Features
    Figure 4. Global DNA & RNA Oligonucleotides Market Share by Application: 2021 VS 2028
    Figure 5. Hospitals and Clinics Case Studies
    Figure 6. Biopharma Companies Case Studies
    Figure 7. Academic & Research Organizations Case Studies
    Figure 8. Others Case Studies
    Figure 9. DNA & RNA Oligonucleotides Report Years Considered
    Figure 10. Global DNA & RNA Oligonucleotides Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global DNA & RNA Oligonucleotides Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global DNA & RNA Oligonucleotides Market Share by Region: 2021 VS 2028
    Figure 13. Global DNA & RNA Oligonucleotides Market Share by Players in 2021
    Figure 14. Global Top DNA & RNA Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by DNA & RNA Oligonucleotides Revenue in 2021
    Figure 16. North America DNA & RNA Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America DNA & RNA Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 18. North America DNA & RNA Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 19. North America DNA & RNA Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 20. United States DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe DNA & RNA Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe DNA & RNA Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 24. Europe DNA & RNA Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 25. Europe DNA & RNA Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 26. Germany DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific DNA & RNA Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific DNA & RNA Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific DNA & RNA Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific DNA & RNA Oligonucleotides Market Size Share by Region (2017-2028)
    Figure 36. China DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America DNA & RNA Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America DNA & RNA Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America DNA & RNA Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America DNA & RNA Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 46. Mexico DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa DNA & RNA Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa DNA & RNA Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa DNA & RNA Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa DNA & RNA Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 52. Turkey DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Eurofins Scientific Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 56. Natera Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 57. BGI Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 58. Illumina Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 59. Roche Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 60. LabCorp Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 61. Berry Genomics Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 62. Brooks Life Sciences Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 63. Macrogen Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 64. Genotypic Technology Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 65. Dna Link Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link
Frequently Asked Questions
DNA & RNA Oligonucleotides report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
DNA & RNA Oligonucleotides report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
DNA & RNA Oligonucleotides report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dry Ice Equipment

Dry Ice Equipment market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More